We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 860 results
  1. Does SANAD II help with gender-specific problems in epilepsy treatment?—English Version

    Gender-specific differences in the treatment of epilepsy are a continuous challenge in the choice of treatment. Earlier studies on antiseizure...

    B. Tettenborn, C. Baumgartner, ... B. J. Steinhoff in Clinical Epileptology
    Article Open access 01 November 2023
  2. Outcomes of a Medication Optimization Virtual Interdisciplinary Geriatric Specialist (MOVING) Program: A Feasibility Study

    Background

    Adverse drug events among older adults result in significant mortality, morbidity and cost. This harm may be mitigated with appropriate...

    Joanne Man-Wai Ho, Eric To, ... Sophiya Benjamin in Drugs - Real World Outcomes
    Article Open access 26 November 2023
  3. Response to Sodium Channel blocking Antiseizure medications and coding polymorphisms of Sodium Channel genes in Taiwanese epilepsy patients

    Background

    Many antiseizure medications (ASMs) control seizures by blocking voltage-dependent sodium channels. Polymorphisms of sodium channel genes...

    Chih-Hsiang Lin, Chen-Jui Ho, ... Meng-Han Tsai in BMC Neurology
    Article Open access 23 September 2021
  4. Brivaracetam and topiramate serum levels during pregnancy and delivery: a case report and a review of literature

    Background

    An increasing use of newer antiseizure medication (ASM) such as SV2A ligand brivaracetam is observed. However, data on newer antiseizure...

    Wiebke Hahn, Leona Möller, ... Susanne Knake in Neurological Research and Practice
    Article Open access 21 March 2024
  5. Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy

    Impairments in cognition are common in epilepsy and may be caused or exacerbated by antiseizure medications (ASMs). Positive effects on cognition may...

    Frank M. C. Besag, Michael J. Vasey in Pediatric Drugs
    Article 06 May 2021
  6. Preferential Antiseizure Medications in Pediatric Patients with Convulsive Status Epilepticus: A Systematic Review and Network Meta-Analysis

    Background and Objective

    The optimal choice for first- and second-line antiseizure medications for pediatric patients with convulsive status...

    Yihao Zhang, Yingjie Liu, ... Zhixiong Liu in Clinical Drug Investigation
    Article 04 November 2020
  7. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis

    Background

    Brivaracetam (BRV), cenobamate (CNB), eslicarbazepine acetate (ESL), lacosamide (LCM) and perampanel (PER) are antiseizure medications...

    Simona Lattanzi, Eugen Trinka, ... Francesco Brigo in Drugs
    Article Open access 21 January 2022
  8. Fenfluramine in clinical practice: new therapy option for Dravet and Lennox–Gastaut syndromes

    Fenfluramine is an antiseizure medication for the treatment of Dravet and Lennox–Gastaut syndromes. This review summarizes the literature on the...

    Hiltrud Muhle, Gerhard Kurlemann, ... Milka Pringsheim in Clinical Epileptology
    Article Open access 03 January 2024
  9. The three pillars in treating antibody-mediated encephalitis

    The rapid initiation of immunotherapy has a decisive impact on the course of the disease in patients with antibody-mediated encephalitis (AE). The...

    S. Macher, G. Bsteh, ... P. S. Rommer in Wiener klinische Wochenschrift
    Article Open access 06 June 2023
  10. Case report of antiseizure medicine-induced long QT syndrome and a literature review

    Background

    To realize the clinical characteristics of long QT syndrome (LQTS) caused by antiseizure medicines (ASMs), and to improve the prevention...

    **ongying Yu, Jian Zha, ... Jianmin Zhong in Acta Epileptologica
    Article Open access 15 November 2022
  11. Antiseizure medications (antiepileptic drugs) in adults: starting, monitoring and stop**

    Up to 10% of people living to 80 years of age have one or more seizures; and many will not require anti-seizure medication (ASMs). In 85% of...

    Heather Angus-Leppan, Michael R. Sperling, Vicente Villanueva in Journal of Neurology
    Article 24 September 2022
  12. Non-adherence and epileptic emergency—reasons and solutions

    Background

    One important cause of epileptic treatment failure and emergency department visits is due to non-adherence. Medication adherence is...

    Isabelle Arnet, Fine Dietrich, ... Samuel S. Allemann in Clinical Epileptology
    Article Open access 14 September 2023
  13. Afebrile benign convulsions with or without a reversible splenial lesion in two pediatric patients with COVID-19

    Background

    Seizures in children with coronavirus disease 2019 (COVID-19) were markedly increased during the Omicron variant surge. Most seizures...

    Yun Young Lee, Young Ok Kim in BMC Pediatrics
    Article Open access 26 April 2023
  14. Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region

    Introduction

    The clinical, social, and economic burden of epilepsy is undeniable. Local guidance on epilepsy management is limited and needed to...

    Taoufik Alsaadi, Abubaker Almadani, ... Riaz Ahmed Khan in Neurology and Therapy
    Article Open access 24 May 2023
  15. Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis

    Introduction

    The aim was to evaluate the efficacy and tolerability of adjunctive brivaracetam (BRV) in adults with severely drug-resistant focal...

    Sang-Kun Lee, Kyoung Heo, ... Boeun Hur in Advances in Therapy
    Article 21 June 2021
  16. The Current Role of Valproic Acid in the Treatment of Epilepsy: A Glimpse into the Present of an Old Ally

    Purpose of the review

    The primary purpose of this review is to explore the specific clinical scenarios where valproic acid demonstrates superiority...

    Camilo Espinosa-Jovel, Natalia Valencia in Current Treatment Options in Neurology
    Article 11 June 2024
  17. Treatment Outcomes of Newly Diagnosed Epilepsy: A Systematic Review and Meta-analysis

    Background and Objectives

    Understanding the multi-faceted treatment outcomes of newly diagnosed epilepsy is critical for develo** rational...

    Mubeen Janmohamed, Haris Hakeem, ... Patrick Kwan in CNS Drugs
    Article 21 December 2022
  18. Variation in electroencephalography and neuroimaging for children receiving extracorporeal membrane oxygenation

    Background

    Seizures, strokes, and intracranial hemorrhage are common and feared complications in children receiving extracorporeal membrane...

    Joseph G. Kohne, Graeme MacLaren, ... Ryan P. Barbaro in Critical Care
    Article Open access 17 January 2023
Did you find what you were looking for? Share feedback.